Home
Search
About
Editorial Board
Contact
Clinical Pearl: What about Antibody Response and Transfer in Pregnant Women Who Have Had SARS-CoV-2 Infection Compared to those Receiving the Vaccine?
April 30, 2021
/
16
,
COVID-19
,
Health
,
Infectious Disease
,
Maternal
,
Vaccines
Joseph R. Hageman, M.D., Mitchell Goldstein, M.D.
nt-21-04-137-139
Download
←
Previous:
When Preterm Infants Struggle to Feed
Next:
Highlights of the 34th Annual Gravens Conference on the Environment of Care for the High-Risk Newborn and Satellite Conference on “Reimagining the NICU”
→